Maintenance treatment with infliximab for the management of Crohn’s disease in adults
Open Access
- 1 January 2009
- journal article
- Published by Informa UK Limited in Biologics: Targets and Therapy
- Vol. 3, 39-49
- https://doi.org/10.2147/btt.2009.2763
Abstract
Peer reviewed article authored by (Renato Caviglia, Ivo Boškoski, Michele Cicala). Read article or submit your manuscript for publishing.Keywords
This publication has 43 references indexed in Scilit:
- Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issuesExpert Opinion on Drug Safety, 2008
- Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized TrialGastroenterology, 2008
- Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune SystemCell, 2007
- Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in ChildrenGastroenterology, 2007
- Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-upWorld Journal of Gastroenterology, 2007
- Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2006
- American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel DiseaseGastroenterology, 2006
- Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies.2004
- The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based studyGastroenterology, 2001
- Inflammatory bowel disease: epidemiology and management in an English general practice populationAlimentary Pharmacology & Therapeutics, 2000